Global GFAP Antibody Market Research Report 2022

SKU ID : QYR-21514972 | Publishing Date : 22-Aug-2022 | No. of pages : 86

Detailed TOC of Global GFAP Antibody Market Research Report 2022

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global GFAP Antibody Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Polyclonal
        1.2.3 Monoclonal
    1.3 Market by Application
        1.3.1 Global GFAP Antibody Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Immunofluorescence
        1.3.3 Western Blot
        1.3.4 Immunohistochemistry Frozen
        1.3.5 Immunohistochemistry Paraffin
        1.3.6 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global GFAP Antibody Market Perspective (2017-2028)
    2.2 GFAP Antibody Growth Trends by Region
        2.2.1 GFAP Antibody Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 GFAP Antibody Historic Market Size by Region (2017-2022)
        2.2.3 GFAP Antibody Forecasted Market Size by Region (2023-2028)
    2.3 GFAP Antibody Market Dynamics
        2.3.1 GFAP Antibody Industry Trends
        2.3.2 GFAP Antibody Market Drivers
        2.3.3 GFAP Antibody Market Challenges
        2.3.4 GFAP Antibody Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top GFAP Antibody Players by Revenue
        3.1.1 Global Top GFAP Antibody Players by Revenue (2017-2022)
        3.1.2 Global GFAP Antibody Revenue Market Share by Players (2017-2022)
    3.2 Global GFAP Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by GFAP Antibody Revenue
    3.4 Global GFAP Antibody Market Concentration Ratio
        3.4.1 Global GFAP Antibody Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by GFAP Antibody Revenue in 2021
    3.5 GFAP Antibody Key Players Head office and Area Served
    3.6 Key Players GFAP Antibody Product Solution and Service
    3.7 Date of Enter into GFAP Antibody Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 GFAP Antibody Breakdown Data by Type
    4.1 Global GFAP Antibody Historic Market Size by Type (2017-2022)
    4.2 Global GFAP Antibody Forecasted Market Size by Type (2023-2028)
5 GFAP Antibody Breakdown Data by Application
    5.1 Global GFAP Antibody Historic Market Size by Application (2017-2022)
    5.2 Global GFAP Antibody Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America GFAP Antibody Market Size (2017-2028)
    6.2 North America GFAP Antibody Market Size by Country (2017-2022)
    6.3 North America GFAP Antibody Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe GFAP Antibody Market Size (2017-2028)
    7.2 Europe GFAP Antibody Market Size by Country (2017-2022)
    7.3 Europe GFAP Antibody Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific GFAP Antibody Market Size (2017-2028)
    8.2 Asia-Pacific GFAP Antibody Market Size by Country (2017-2022)
    8.3 Asia-Pacific GFAP Antibody Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America GFAP Antibody Market Size (2017-2028)
    9.2 Latin America GFAP Antibody Market Size by Country (2017-2022)
    9.3 Latin America GFAP Antibody Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa GFAP Antibody Market Size (2017-2028)
    10.2 Middle East & Africa GFAP Antibody Market Size by Country (2017-2022)
    10.3 Middle East & Africa GFAP Antibody Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Aviva Systems Biology
        11.1.1 Aviva Systems Biology Company Detail
        11.1.2 Aviva Systems Biology Business Overview
        11.1.3 Aviva Systems Biology GFAP Antibody Introduction
        11.1.4 Aviva Systems Biology Revenue in GFAP Antibody Business (2017-2022)
        11.1.5 Aviva Systems Biology Recent Development
    11.2 Merck
        11.2.1 Merck Company Detail
        11.2.2 Merck Business Overview
        11.2.3 Merck GFAP Antibody Introduction
        11.2.4 Merck Revenue in GFAP Antibody Business (2017-2022)
        11.2.5 Merck Recent Development
    11.3 FineTest
        11.3.1 FineTest Company Detail
        11.3.2 FineTest Business Overview
        11.3.3 FineTest GFAP Antibody Introduction
        11.3.4 FineTest Revenue in GFAP Antibody Business (2017-2022)
        11.3.5 FineTest Recent Development
    11.4 Santa Cruz Biotechnology
        11.4.1 Santa Cruz Biotechnology Company Detail
        11.4.2 Santa Cruz Biotechnology Business Overview
        11.4.3 Santa Cruz Biotechnology GFAP Antibody Introduction
        11.4.4 Santa Cruz Biotechnology Revenue in GFAP Antibody Business (2017-2022)
        11.4.5 Santa Cruz Biotechnology Recent Development
    11.5 Miltenyi Biotec
        11.5.1 Miltenyi Biotec Company Detail
        11.5.2 Miltenyi Biotec Business Overview
        11.5.3 Miltenyi Biotec GFAP Antibody Introduction
        11.5.4 Miltenyi Biotec Revenue in GFAP Antibody Business (2017-2022)
        11.5.5 Miltenyi Biotec Recent Development
    11.6 Sino Biological
        11.6.1 Sino Biological Company Detail
        11.6.2 Sino Biological Business Overview
        11.6.3 Sino Biological GFAP Antibody Introduction
        11.6.4 Sino Biological Revenue in GFAP Antibody Business (2017-2022)
        11.6.5 Sino Biological Recent Development
    11.7 Enzo Life Sciences
        11.7.1 Enzo Life Sciences Company Detail
        11.7.2 Enzo Life Sciences Business Overview
        11.7.3 Enzo Life Sciences GFAP Antibody Introduction
        11.7.4 Enzo Life Sciences Revenue in GFAP Antibody Business (2017-2022)
        11.7.5 Enzo Life Sciences Recent Development
    11.8 Proteintech
        11.8.1 Proteintech Company Detail
        11.8.2 Proteintech Business Overview
        11.8.3 Proteintech GFAP Antibody Introduction
        11.8.4 Proteintech Revenue in GFAP Antibody Business (2017-2022)
        11.8.5 Proteintech Recent Development
    11.9 Atlas Antibodies
        11.9.1 Atlas Antibodies Company Detail
        11.9.2 Atlas Antibodies Business Overview
        11.9.3 Atlas Antibodies GFAP Antibody Introduction
        11.9.4 Atlas Antibodies Revenue in GFAP Antibody Business (2017-2022)
        11.9.5 Atlas Antibodies Recent Development
    11.10 GeneTex
        11.10.1 GeneTex Company Detail
        11.10.2 GeneTex Business Overview
        11.10.3 GeneTex GFAP Antibody Introduction
        11.10.4 GeneTex Revenue in GFAP Antibody Business (2017-2022)
        11.10.5 GeneTex Recent Development
    11.11 Synaptic Systems
        11.11.1 Synaptic Systems Company Detail
        11.11.2 Synaptic Systems Business Overview
        11.11.3 Synaptic Systems GFAP Antibody Introduction
        11.11.4 Synaptic Systems Revenue in GFAP Antibody Business (2017-2022)
        11.11.5 Synaptic Systems Recent Development
    11.12 Hytest
        11.12.1 Hytest Company Detail
        11.12.2 Hytest Business Overview
        11.12.3 Hytest GFAP Antibody Introduction
        11.12.4 Hytest Revenue in GFAP Antibody Business (2017-2022)
        11.12.5 Hytest Recent Development
    11.13 ProSci
        11.13.1 ProSci Company Detail
        11.13.2 ProSci Business Overview
        11.13.3 ProSci GFAP Antibody Introduction
        11.13.4 ProSci Revenue in GFAP Antibody Business (2017-2022)
        11.13.5 ProSci Recent Development
    11.14 EnCor Biotechnology
        11.14.1 EnCor Biotechnology Company Detail
        11.14.2 EnCor Biotechnology Business Overview
        11.14.3 EnCor Biotechnology GFAP Antibody Introduction
        11.14.4 EnCor Biotechnology Revenue in GFAP Antibody Business (2017-2022)
        11.14.5 EnCor Biotechnology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Figures, Tables and Charts Available in Global GFAP Antibody Market Research Report 2022

List of Tables
    Table 1. Global GFAP Antibody Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Polyclonal
    Table 3. Key Players of Monoclonal
    Table 4. Global GFAP Antibody Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global GFAP Antibody Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global GFAP Antibody Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global GFAP Antibody Market Share by Region (2017-2022)
    Table 8. Global GFAP Antibody Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global GFAP Antibody Market Share by Region (2023-2028)
    Table 10. GFAP Antibody Market Trends
    Table 11. GFAP Antibody Market Drivers
    Table 12. GFAP Antibody Market Challenges
    Table 13. GFAP Antibody Market Restraints
    Table 14. Global GFAP Antibody Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global GFAP Antibody Market Share by Players (2017-2022)
    Table 16. Global Top GFAP Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GFAP Antibody as of 2021)
    Table 17. Ranking of Global Top GFAP Antibody Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by GFAP Antibody Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players GFAP Antibody Product Solution and Service
    Table 21. Date of Enter into GFAP Antibody Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global GFAP Antibody Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global GFAP Antibody Revenue Market Share by Type (2017-2022)
    Table 25. Global GFAP Antibody Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global GFAP Antibody Revenue Market Share by Type (2023-2028)
    Table 27. Global GFAP Antibody Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global GFAP Antibody Revenue Market Share by Application (2017-2022)
    Table 29. Global GFAP Antibody Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global GFAP Antibody Revenue Market Share by Application (2023-2028)
    Table 31. North America GFAP Antibody Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America GFAP Antibody Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe GFAP Antibody Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe GFAP Antibody Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific GFAP Antibody Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific GFAP Antibody Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America GFAP Antibody Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America GFAP Antibody Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa GFAP Antibody Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa GFAP Antibody Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Aviva Systems Biology Company Detail
    Table 42. Aviva Systems Biology Business Overview
    Table 43. Aviva Systems Biology GFAP Antibody Product
    Table 44. Aviva Systems Biology Revenue in GFAP Antibody Business (2017-2022) & (US$ Million)
    Table 45. Aviva Systems Biology Recent Development
    Table 46. Merck Company Detail
    Table 47. Merck Business Overview
    Table 48. Merck GFAP Antibody Product
    Table 49. Merck Revenue in GFAP Antibody Business (2017-2022) & (US$ Million)
    Table 50. Merck Recent Development
    Table 51. FineTest Company Detail
    Table 52. FineTest Business Overview
    Table 53. FineTest GFAP Antibody Product
    Table 54. FineTest Revenue in GFAP Antibody Business (2017-2022) & (US$ Million)
    Table 55. FineTest Recent Development
    Table 56. Santa Cruz Biotechnology Company Detail
    Table 57. Santa Cruz Biotechnology Business Overview
    Table 58. Santa Cruz Biotechnology GFAP Antibody Product
    Table 59. Santa Cruz Biotechnology Revenue in GFAP Antibody Business (2017-2022) & (US$ Million)
    Table 60. Santa Cruz Biotechnology Recent Development
    Table 61. Miltenyi Biotec Company Detail
    Table 62. Miltenyi Biotec Business Overview
    Table 63. Miltenyi Biotec GFAP Antibody Product
    Table 64. Miltenyi Biotec Revenue in GFAP Antibody Business (2017-2022) & (US$ Million)
    Table 65. Miltenyi Biotec Recent Development
    Table 66. Sino Biological Company Detail
    Table 67. Sino Biological Business Overview
    Table 68. Sino Biological GFAP Antibody Product
    Table 69. Sino Biological Revenue in GFAP Antibody Business (2017-2022) & (US$ Million)
    Table 70. Sino Biological Recent Development
    Table 71. Enzo Life Sciences Company Detail
    Table 72. Enzo Life Sciences Business Overview
    Table 73. Enzo Life Sciences GFAP Antibody Product
    Table 74. Enzo Life Sciences Revenue in GFAP Antibody Business (2017-2022) & (US$ Million)
    Table 75. Enzo Life Sciences Recent Development
    Table 76. Proteintech Company Detail
    Table 77. Proteintech Business Overview
    Table 78. Proteintech GFAP Antibody Product
    Table 79. Proteintech Revenue in GFAP Antibody Business (2017-2022) & (US$ Million)
    Table 80. Proteintech Recent Development
    Table 81. Atlas Antibodies Company Detail
    Table 82. Atlas Antibodies Business Overview
    Table 83. Atlas Antibodies GFAP Antibody Product
    Table 84. Atlas Antibodies Revenue in GFAP Antibody Business (2017-2022) & (US$ Million)
    Table 85. Atlas Antibodies Recent Development
    Table 86. GeneTex Company Detail
    Table 87. GeneTex Business Overview
    Table 88. GeneTex GFAP Antibody Product
    Table 89. GeneTex Revenue in GFAP Antibody Business (2017-2022) & (US$ Million)
    Table 90. GeneTex Recent Development
    Table 91. Synaptic Systems Company Detail
    Table 92. Synaptic Systems Business Overview
    Table 93. Synaptic Systems GFAP AntibodyProduct
    Table 94. Synaptic Systems Revenue in GFAP Antibody Business (2017-2022) & (US$ Million)
    Table 95. Synaptic Systems Recent Development
    Table 96. Hytest Company Detail
    Table 97. Hytest Business Overview
    Table 98. Hytest GFAP AntibodyProduct
    Table 99. Hytest Revenue in GFAP Antibody Business (2017-2022) & (US$ Million)
    Table 100. Hytest Recent Development
    Table 101. ProSci Company Detail
    Table 102. ProSci Business Overview
    Table 103. ProSci GFAP AntibodyProduct
    Table 104. ProSci Revenue in GFAP Antibody Business (2017-2022) & (US$ Million)
    Table 105. ProSci Recent Development
    Table 106. EnCor Biotechnology Company Detail
    Table 107. EnCor Biotechnology Business Overview
    Table 108. EnCor Biotechnology GFAP AntibodyProduct
    Table 109. EnCor Biotechnology Revenue in GFAP Antibody Business (2017-2022) & (US$ Million)
    Table 110. EnCor Biotechnology Recent Development
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global GFAP Antibody Market Share by Type: 2021 VS 2028
    Figure 2. Polyclonal Features
    Figure 3. Monoclonal Features
    Figure 4. Global GFAP Antibody Market Share by Application in 2021 & 2028
    Figure 5. Immunofluorescence Case Studies
    Figure 6. Western Blot Case Studies
    Figure 7. Immunohistochemistry Frozen Case Studies
    Figure 8. Immunohistochemistry Paraffin Case Studies
    Figure 9. Others Case Studies
    Figure 10. GFAP Antibody Report Years Considered
    Figure 11. Global GFAP Antibody Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global GFAP Antibody Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global GFAP Antibody Market Share by Region: 2021 VS 2028
    Figure 14. Global GFAP Antibody Market Share by Players in 2021
    Figure 15. Global Top GFAP Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GFAP Antibody as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by GFAP Antibody Revenue in 2021
    Figure 17. North America GFAP Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. North America GFAP Antibody Market Share by Country (2017-2028)
    Figure 19. United States GFAP Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada GFAP Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe GFAP Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe GFAP Antibody Market Share by Country (2017-2028)
    Figure 23. Germany GFAP Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. France GFAP Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. U.K. GFAP Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Italy GFAP Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Russia GFAP Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Nordic Countries GFAP Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific GFAP Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific GFAP Antibody Market Share by Region (2017-2028)
    Figure 31. China GFAP Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Japan GFAP Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. South Korea GFAP Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Southeast Asia GFAP Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. India GFAP Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Australia GFAP Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America GFAP Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America GFAP Antibody Market Share by Country (2017-2028)
    Figure 39. Mexico GFAP Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Brazil GFAP Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa GFAP Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa GFAP Antibody Market Share by Country (2017-2028)
    Figure 43. Turkey GFAP Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Saudi Arabia GFAP Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Aviva Systems Biology Revenue Growth Rate in GFAP Antibody Business (2017-2022)
    Figure 46. Merck Revenue Growth Rate in GFAP Antibody Business (2017-2022)
    Figure 47. FineTest Revenue Growth Rate in GFAP Antibody Business (2017-2022)
    Figure 48. Santa Cruz Biotechnology Revenue Growth Rate in GFAP Antibody Business (2017-2022)
    Figure 49. Miltenyi Biotec Revenue Growth Rate in GFAP Antibody Business (2017-2022)
    Figure 50. Sino Biological Revenue Growth Rate in GFAP Antibody Business (2017-2022)
    Figure 51. Enzo Life Sciences Revenue Growth Rate in GFAP Antibody Business (2017-2022)
    Figure 52. Proteintech Revenue Growth Rate in GFAP Antibody Business (2017-2022)
    Figure 53. Atlas Antibodies Revenue Growth Rate in GFAP Antibody Business (2017-2022)
    Figure 54. GeneTex Revenue Growth Rate in GFAP Antibody Business (2017-2022)
    Figure 55. Synaptic Systems Revenue Growth Rate in GFAP Antibody Business (2017-2022)
    Figure 56. Hytest Revenue Growth Rate in GFAP Antibody Business (2017-2022)
    Figure 57. ProSci Revenue Growth Rate in GFAP Antibody Business (2017-2022)
    Figure 58. EnCor Biotechnology Revenue Growth Rate in GFAP Antibody Business (2017-2022)
    Figure 59. Bottom-up and Top-down Approaches for This Report
    Figure 60. Data Triangulation
    Figure 61. Key Executives Interviewed

Keyplayers in Global GFAP Antibody Market Research Report 2022

Aviva Systems Biology
Merck
FineTest
Santa Cruz Biotechnology
Miltenyi Biotec
Sino Biological
Enzo Life Sciences
Proteintech
Atlas Antibodies
GeneTex
Synaptic Systems
Hytest
ProSci
EnCor Biotechnology